IART
Integra LifeSciences Holdings
NASDAQ: IART · HEALTHCARE · MEDICAL DEVICES
$10.54
+4.56% today
Updated 2026-04-30
Market cap
$785.61M
P/E ratio
—
P/S ratio
0.48x
EPS (TTM)
$-6.74
Dividend yield
—
52W range
$9 – $17
Volume
0.8M
Integra LifeSciences Holdings (IART) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $448.43M | $613.62M | $818.01M | $1.03B | $940.10M | $1.02B | $1.14B | $1.16B | $1.20B | $1.58B | $1.77B | $1.81B | $3.21B | $3.11B | $3.30B | $3.62B | $3.78B | $3.89B | $3.78B | $4.04B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $265.95M | $221.76M | $339.93M | $497.39M | $365.36M | $444.85M | $452.26M | $453.05M | $525.24M | $529.32M | $438.50M | $495.17M | $822.15M | $775.08M | $858.17M | $1.24B | $1.15B | $1.16B | $1.06B | $1.08B |
| Total liabilities | $158.61M | $317.46M | $557.58M | $684.23M | $495.22M | $517.35M | $651.47M | $645.82M | $526.05M | $874.30M | $1.02B | $968.29M | $2.25B | $1.73B | $1.89B | $2.10B | $2.10B | $2.09B | $2.19B | $2.49B |
| Current liabilities | $31.29M | $274.02M | $191.67M | $174.75M | $156.73M | $200.03M | $101.87M | $106.93M | $119.38M | $126.03M | $139.13M | $123.60M | $348.91M | $262.55M | $331.31M | $401.01M | $340.02M | $320.91M | $306.98M | $922.13M |
| Long-term debt | $118.38M | $508000.00 | $330.00M | $490.00M | $308.75M | $294.84M | $532.26M | $519.55M | $392.06M | $626.25M | $700.60M | $665.00M | $1.78B | $1.21B | $1.20B | $1.41B | $1.39B | $1.30B | $1.49B | $1.20B |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $36.93M | $66.34M | $98.17M | $132.22M | $167.16M | $232.83M | $260.82M | $302.02M | $285.05M | $314.96M | $145.88M | $220.44M | $285.19M | $348.37M | $398.57M | $532.26M | $698.57M | $879.12M | $946.86M | $939.91M |
| Accounts receivable | $49.01M | $85.02M | $103.54M | $112.42M | $103.23M | $106.00M | $118.13M | $114.92M | $118.14M | $131.92M | $132.24M | $148.19M | $251.80M | $265.74M | $275.30M | $225.53M | $231.83M | $263.46M | $259.33M | $272.37M |
| Inventory | $67.48M | $94.39M | $144.53M | $146.10M | $140.24M | $146.93M | $171.26M | $171.81M | $213.43M | $237.11M | $211.43M | $217.26M | $296.33M | $280.35M | $316.05M | $310.12M | $317.39M | $324.58M | $389.61M | $429.09M |
| Goodwill | $68.36M | $162.41M | $207.44M | $212.09M | $261.94M | $261.93M | $292.98M | $294.07M | $249.76M | $363.89M | $512.39M | $510.57M | $937.90M | $926.48M | $954.28M | $932.37M | $1.01B | $1.04B | $1.06B | $1.10B |